Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-25 Option Award |
2021-05-27 4:57 pm |
N/A 2031-05-24 |
Allovir Inc. | ALVR | GADICKE ANSBERT Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2021-05-18 Other |
2021-05-20 7:56 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
21,834 | $0 | 4,625,934 (Indirect) |
View |
| 2021-05-04 Conversion |
2021-05-06 4:19 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner |
57,683,698 | $0 | 6,672,183 (Indirect) |
View |
Ownership |
2021-04-29 5:31 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | GADICKE ANSBERT MPM ONCOLOGY INNOVATIONS FUND LP UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Innovations Fund GP LLC MPM Oncology Impact Management GP LLC 10% Owner |
0 | $0 | 6,486,087 (Indirect) |
View |
| 2021-04-07 Other |
2021-04-09 4:47 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC 10% Owner |
15,670 | $0 | 6,020,238 (Indirect) |
View |
| 2021-03-15 Other |
2021-03-15 5:10 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
24,271 | $0 | 4,697,109 (Indirect) |
View |
| 2021-01-20 Other |
2021-01-22 8:16 pm |
N/A N/A |
Harpoon Therapeutics Inc. | HARP | MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd GADICKE ANSBERT EVNIN LUKE 10% Owner |
101,646 | $0 | 8,354,392 (Indirect) |
View |
| 2021-01-07 Other |
2021-01-14 5:51 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
8,246,093 | $0 | 16,441,248 (Indirect) |
View |
| 2021-01-12 Conversion |
2021-01-14 5:51 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
7,613,887 | $0 | 16,441,248 (Indirect) |
View |
Ownership |
2021-01-07 8:37 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
0 | $0 | 8,246,093 (Direct) |
View |
| 2020-07-23 Option Award(A) |
2020-10-21 4:56 pm |
N/A 2030-07-23 |
iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT Director 10% Owner |
16,608 | $0 | 0 (Direct) |
View |
| 2020-10-06 Conversion |
2020-10-08 6:28 pm |
N/A N/A |
Oncorus Inc. | ONCR | GADICKE ANSBERT 10% Owner |
4,785,655 | $0 | 2,377,025 (Indirect) |
View |
Ownership |
2020-10-01 7:05 pm |
N/A N/A |
Oncorus Inc. | ONCR | GADICKE ANSBERT 10% Owner |
0 | $0 | 4,971,279 (Indirect) |
View |
| 2020-09-21 Conversion |
2020-09-23 7:12 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | MPM BIOVENTURES 2018 L.P. MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM BioVentures 2018 GP LLC MPM BioVentures 2018 LLC EVNIN LUKE Foley Todd GADICKE ANSBERT 10% Owner |
21,374,284 | $0 | 91,081 (Indirect) |
View |
Ownership |
2020-09-16 8:49 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | MPM BIOVENTURES 2018 L.P. MPM BIOVENTURES 2018 (B) L.P. MPM ASSET MANAGEMENT INVESTORS BV2018 LLC MPM BioVentures 2018 GP LLC MPM BioVentures 2018 LLC EVNIN LUKE Foley Todd GADICKE ANSBERT 10% Owner |
0 | $0 | 4,951,303 (Indirect) |
View |
| 2020-08-03 Conversion |
2020-08-05 9:50 pm |
N/A N/A |
Allovir Inc. | ALVR | GADICKE ANSBERT Director 10% Owner |
33,420,970 | $0 | 13,451,167 (Indirect) |
View |
| 2020-07-29 Option Award |
2020-07-31 6:34 pm |
N/A 2030-07-29 |
Allovir Inc. | ALVR | GADICKE ANSBERT Director 10% Owner |
22,500 | $0 | 22,500 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-30 08:00 am |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | GADICKE ANSBERT UBS Oncology Impact Fund L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP Oncology Impact Fund (Cayman) Management L.P. Director 10% Owner |
23,558,112 | $0 | 2,355,557 (Indirect) |
View |